Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Dongyangguang Pharmaceutical's insulin glargine injection has been approved for marketing by the US FDA

Dongyangguang Pharmaceutical's insulin glargine injection has been approved for marketing by the US FDA

老虎证券老虎证券2026/05/04 02:11
Show original
The product has also received the "interchangeable" label, allowing it to directly replace the original drug Lantus at the pharmacy level.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!